SULF2 and B-cell chronic lymphocytic leukemia: Furthermore our work leads us to propose that the expression levels of MYC, SULF2, miR-29a, miR-181a and miR-221a measured in CLL patients could be of interest during clinical trials and may help to predict the chemo-refractory character of patients.